Postoperative detection of circulating EGFR transcripts as a surrogate marker for circulating tumor cells to predict tumor recurrence after adjuvant radio(chemo)therapy in locally advanced squamous cell carcinoma of the head and neck (LASCCHN).
Inge Tinhofer
Honoraria - Merck Serono
Research Funding - Merck Serono
Robert Konschak
No relevant relationships to disclose
Carmen Stromberger
No relevant relationships to disclose
Ulrich Keilholz
Honoraria - Merck Serono
Research Funding - Merck Serono
Volker Budach
Honoraria - Merck Serono